Suzhou Basecare Medical Corporation Limited (HKG:2170)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.200
+0.080 (2.56%)
Apr 25, 2025, 3:27 PM HKT

Suzhou Basecare Medical Corporation Company Description

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia.

The company offers genetic test kit products, which include pre-implantation genetic test kits, such as PGT-A to detect aneuploidy; PGT-M to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage.

It also offers liquid nitrogen storage dewar, Cryopreservation system, and sperm quality analyzer; universal kits for sequencing effects; sample preservation solution; and nucleic acid purification and DNA extraction kits.

The company also engages in the research, development, manufacture, and sale of testing kits, testing devices, and instruments.

In addition, it provides marketing services; and engages in the research and development of software for testing devices and instruments.

The company serves hospitals and reproductive clinics. Suzhou Basecare Medical Corporation Limited was incorporated in 2010 and is headquartered in Suzhou, China.

Suzhou Basecare Medical Corporation Limited
Country China
Founded 2010
Industry Medical Devices
Sector Healthcare
Employees 497
CEO Bo Liang

Contact Details

Address:
Building A3 BioBay
Suzhou
China
Website basecare.cn

Stock Details

Ticker Symbol 2170
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100004BC1
SIC Code 2835

Key Executives

Name Position
Dr. Bo Liang Ph.D. Chairman of the Board and GM
Lingyin Kong Chief Technology Officer and Executive Director
Ying Yang Chief Quality Officer